Deutliche Verbesserung des Gesamtüberlebens durch Sacituzumab-Govitecan beim metastasierten tripelnegativen Mammakarzinom

Translated title of the contribution: Significant improvement of overall survival with sacituzumab govitecan in metastatic triple-negative breast cancer

Mascha Pervan*, Natalia Krawczyk, Lars Hanker, Nana Bündgen, Achim Rody, M. Banys-Paluchowski

*Corresponding author for this work
Translated title of the contributionSignificant improvement of overall survival with sacituzumab govitecan in metastatic triple-negative breast cancer
Original languageGerman
JournalOnkologe
Volume27
Issue number11
Pages (from-to)1131-1136
Number of pages6
ISSN0947-8965
DOIs
Publication statusPublished - 11.2021

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

Cite this